Stocks to Watch: Ecolab, Paramount and More

me 2/19/2023 12:12:00 AM

Stock to Watch: West Pharmaceutical Services Inc. (NYSE: WST)

This healthcare stock was up 17.9% this week.
33.3% of Wall Street analysts recommend buying this stock.
The average downside to its target price is 7.2%.

Stock to Watch: Ecolab Inc (NYSE: ECL)

This materials (non-energy) stock was up 10.5% this week.
34.6% of Wall Street analysts recommend buying this stock.
The average upside to its target price is 3.8%.

Stock to Watch: Paramount Global (NASDAQ: PARA)

This consumer services stock was up 9.2% this week.
21.4% of Wall Street analysts recommend buying this stock.
The average downside to its target price is 13.4%.

Stock to Watch: Zoetics Inc (NYSE: ZTS)

This healthcare stock was up 9.1% this week.
75% of Wall Street analysts recommend buying this stock.
The average upside to its target price is 25.3%.

Stock to Watch: Generac Holdings (NYSE: GNRC)

This industrials stock was up 8.4% this week.
54.2% of Wall Street analysts recommend buying this stock.
The average upside to its target price is 12.5%.

Stock to Watch: Cisco System Inc (NASDAQ: CSCO)

This technology stock was up 8.3% this week.
40.7% of Wall Street analysts recommend buying this stock.
The average upside to its target price is 11.1%.

Stock to Watch: Analog Devices (NASDAQ: ADI)

This technology stock was up 8.2% this week.
58.1% of Wall Street analysts recommend buying this stock.
The average upside to its target price is 12%.

Stock to Watch: Norwegian Cruise Line Holdings Ltd (NYSE: NCLH)

This consumer services stock was up 8.1% this week.
38.9% of Wall Street analysts recommend buying this stock.
The average downside to its target price is 3.9%.

Stock to Watch: Warner Bros Discovery Inc (NASDAQ: WBD)

This consumer services stock was up 7% this week.
48.1% of Wall Street analysts recommend buying this stock.
The average downside to its target price is 34.1%.

Stock to Watch: Illumina (NASDAQ: ILMN)

This healthcare stock was up 6.1% this week.
34.8% of Wall Street analysts recommend buying this stock.
The average downside to its target price is 12.3%.